| CYSB2500113 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-05-20 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CXSL2500277 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.2) | New Drug Application | 2025-04-08 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2500044 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-02-19 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| JYSB2500006 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2500004 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2500005 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2500007 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| CYSB2400105 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2024-05-08 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2400043 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2024-02-20 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CXSL2400072 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-01-31 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2300595 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-09-02 | | Hualan Biological Engineering Inc | | | view |
| CXSL2300529 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-08-01 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
| CYSB2300147 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2023-07-28 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2300115 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2023-06-14 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CXSL2300259 | 注射用培重组人凝血因子IX-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2023-04-14 | | Zhengzhou Shengsi Biotechnology Co Ltd | | | view |
| CXSL2300260 | 注射用培重组人凝血因子IX-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2023-04-14 | | Zhengzhou Shengsi Biotechnology Co Ltd | | | view |
| JYSZ2200035 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
| JYSZ2200036 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
| JYSZ2200034 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
| JYSZ2200033 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
